1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
9th Invest in ME International ME Conference, 2014 - Part 1: Autoimmunity and ME
Mark Berry begins a series of articles on the 9th Invest in ME International ME Conference in London, with a look at three presentations on autoimmunity
Discuss the article on the Forums.

Guess we (ME patients) lost

Discussion in 'Action Alerts and Advocacy' started by Jill McLaughlin, Nov 19, 2011.

  1. Jill McLaughlin

    Jill McLaughlin *****

    Messages:
    196
    Likes:
    5
    Sorry, nothing new.

    The Coalition 4 ME/CFS apparently won. We can't even go to Congress.
    This was foisted on us by the so-called patient groups.

    Same mixed cohorts. Garbage in-garbage out.

    Keep writing petitions for fairness and apologies.


    -------
    NIH grant proposal announcement: Myalgic Encephalomyelitis/Chronic
    Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment
    (R21)

    This Funding Opportunity Announcement (FOA) issued by the Office of
    Research on Women's Health (ORWH) and co-sponsoring Institutes and
    Centers (ICs) of the National Institutes of Health (NIH) encourages
    investigator(s)-initiated applications that propose to examine the
    etiology, diagnosis, pathophysiology, and treatment of chronic fatigue
    syndrome (CFS), sometimes referred to as myalgic encephalomyelitis
    (ME), in diverse groups and across the lifespan.

    Applications that address gaps in the understanding of the
    environmental and biological risk factors, the determinants of
    heterogeneity among patient populations, the common mechanisms
    influencing the multiple body systems that are affected in ME/CFS are
    encouraged.

    The NIH is particularly interested in funding interdisciplinary
    research that will enhance our knowledge of the disease process and
    provide evidence based solutions to improve the diagnosis, treatment,
    and quality of life of all persons with ME/CFS. This interdisciplinary
    research may include the building of scientific teams to study and
    develop biomarkers, innovative treatment modalities, and/or the
    modifiable risk and protective processes specifically targeted by
    preventive and/or treatment interventions.

    Applications submitted under this mechanism should be exploratory and
    novel, and should break new ground or extend previous discoveries
    toward new directions or applications.

    Further details can be found here:
    http://grants.nih.gov/grants/guide/pa-files/PAR-12-033.html

See more popular forum discussions.

Share This Page